About Amicus Therapeutics

Amicus Therapeutics is a leading, global biotechnology company focused on discovering, developing and delivering high quality medicines for people living with rare diseases. Founded in 2002 with patients at the centre of everything they do, Amicus pushes ideas as far and as fast as possible because every moment matters when living with a rare disease. The company focuses on rare metabolic disorders including Fabry disease and Pompe disease, developing treatments that transform outcomes for patients and their families. Guided by founding beliefs centered on patient advocacy, innovation and teamwork, Amicus combines rigorous science with an unwavering commitment to the rare disease community.